Q3 Earnings: Surveying The Small Biopharma Launch Scene
Several small biopharmas are launching new drugs independently, sales of some of those drugs appear to be off to a slow start.
Several small biopharmas are launching new drugs independently, sales of some of those drugs appear to be off to a slow start.